Nutrient quality
Very high-dose methylfolate with glycine in capsules gives the formula reasonable ingredient quality. The disclosed amounts are meaningful and the ingredient selection stays focused.
| $ 57.00 | ||
| $ 57.00 | ||
| $ 57.00 |
The capsule supplies L-methylfolate equivalent to 25 mg DFE. Such an extremely high active-folate amount requires a defined clinical rationale.
Glycine is present at 250 mg, far below a useful standalone amount. Its source quality is not described, and it adds little to the formula's value.
Sixty one-capsule servings support a set regimen but do not reduce the need for monitoring. B12 status, mood changes, and medication context should determine whether it fits.
Very high-dose methylfolate with glycine in capsules gives the formula reasonable ingredient quality. The disclosed amounts are meaningful and the ingredient selection stays focused.
Important active details are incomplete or internally inconsistent. Serving guidance and the complete inactive-ingredient list are not fully supplied.
The aggregate rating is strong but the review volume limits confidence. No review excerpts are supplied to assess repeated complaints or purpose-specific experiences.
Premium positioning or disclosure limits weaken the value case. The useful active content appears limited relative to the serving cost.
| Ingredient | Amount per serving |
|---|---|
Folate | 25 mg DFE |
Glycine | 250 mg |
The clearly stated glycine amount is far below a targeted dose and mainly supports a high-dose methylfolate product. Standard capsule delivery is convenient, but the glycine source has no premium purity marker. The high cost offers weak glycine value and is justified only by the primary methylfolate use.